Investors' belief that the company's revenue growth might un...
Investors' belief that the company's revenue growth might underperform the broader industry is causing a low P/S ratio. The company's recent medium-term revenue decline is contributing to its low P/S, and the share price is unlikely to experience significant movement if these trends persist.
Jiangsu Nanfang Medical Co., Ltd. (SHSE:603880) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment